Literature DB >> 27164705

Absence of Lewy pathology associated with PINK1 homozygous mutation.

Masashi Takanashi1, Yuanzhe Li2, Nobutaka Hattori2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27164705     DOI： 10.1212/WNL.0000000000002744

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  18 in total

Review 1.  Parkin and PINK1 functions in oxidative stress and neurodegeneration.

Authors:  Sandeep K Barodia; Rose B Creed; Matthew S Goldberg
Journal:  Brain Res Bull       Date:  2016-12-23       Impact factor: 4.077

Review 2.  Neuropathology of Parkinson disease.

Authors:  Dennis W Dickson
Journal:  Parkinsonism Relat Disord       Date:  2017-08-01       Impact factor: 4.891

3.  Reply: Heterozygous PINK1 p.G411S in rapid eye movement sleep behaviour disorder.

Authors:  Andreas Puschmann; Fabienne C Fiesel; Thomas R Caulfield; Roman Hudec; Maya Ando; Dominika Truban; Xu Hou; Kotaro Ogaki; Michael G Heckman; Elle D James; Maria Swanberg; Itzia Jimenez-Ferrer; Oskar Hansson; Grzegorz Opala; Joanna Siuda; Magdalena Boczarska-Jedynak; Andrzej Friedman; Dariusz Koziorowski; Monika Rudzinska-Bar; Jan O Aasly; Timothy Lynch; George D Mellick; Megha Mohan; Peter A Silburn; Yanosh Sanotsky; Carles Vilariño-Güell; Matthew J Farrer; Li Chen; Valina L Dawson; Ted M Dawson; Zbigniew K Wszolek; Owen A Ross; Wolfdieter Springer
Journal:  Brain       Date:  2017-06-01       Impact factor: 13.501

Review 4.  iPS cells in the study of PD molecular pathogenesis.

Authors:  Melanie M Cobb; Abinaya Ravisankar; Gaia Skibinski; Steven Finkbeiner
Journal:  Cell Tissue Res       Date:  2017-12-12       Impact factor: 5.249

Review 5.  PINK1, Parkin, and Mitochondrial Quality Control: What can we Learn about Parkinson's Disease Pathobiology?

Authors:  Dominika Truban; Xu Hou; Thomas R Caulfield; Fabienne C Fiesel; Wolfdieter Springer
Journal:  J Parkinsons Dis       Date:  2017       Impact factor: 5.568

Review 6.  Ubiquitin and Parkinson's disease through the looking glass of genetics.

Authors:  Helen Walden; Miratul M K Muqit
Journal:  Biochem J       Date:  2017-04-13       Impact factor: 3.857

7.  Identifying Therapeutic Agents for Amelioration of Mitochondrial Clearance Disorder in Neurons of Familial Parkinson Disease.

Authors:  Akihiro Yamaguchi; Kei-Ichi Ishikawa; Tsuyoshi Inoshita; Kahori Shiba-Fukushima; Shinji Saiki; Taku Hatano; Akio Mori; Yutaka Oji; Ayami Okuzumi; Yuanzhe Li; Manabu Funayama; Yuzuru Imai; Nobutaka Hattori; Wado Akamatsu
Journal:  Stem Cell Reports       Date:  2020-05-28       Impact factor: 7.765

Review 8.  Are PARKIN patients ideal candidates for dopaminergic cell replacement therapies?

Authors:  Tilo Kunath; Ammar Natalwala; Claire Chan; Yixi Chen; Benjamin Stecher; Martin Taylor; Sadaquate Khan; Miratul M K Muqit
Journal:  Eur J Neurosci       Date:  2019-01-23       Impact factor: 3.386

9.  PINK1 phosphorylates ubiquitin predominantly in astrocytes.

Authors:  Sandeep K Barodia; Laura J McMeekin; Rose B Creed; Elijah K Quinones; Rita M Cowell; Matthew S Goldberg
Journal:  NPJ Parkinsons Dis       Date:  2019-12-11

10.  Isolated nigral degeneration without pathological protein aggregation in autopsied brains with LRRK2 p.R1441H homozygous and heterozygous mutations.

Authors:  Masashi Takanashi; Manabu Funayama; Eiji Matsuura; Hiroyo Yoshino; Yuanzhe Li; Sho Tsuyama; Hiroshi Takashima; Kenya Nishioka; Nobutaka Hattori
Journal:  Acta Neuropathol Commun       Date:  2018-10-17       Impact factor: 7.801
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.